✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Kymera Therapeutics Inc

Common Name
Kymera Therapeutics
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
253
Ticker
KYMR
Exchange
NASDAQ/NMS
Description
Kymera Therapeutics Inc. is a pioneering biotechnology company focused on the development of targeted protein degradation therapies. These therapies are aimed at disease-causing proteins that have tra...

Kymera Therapeutics's Revenues Data

Explore Kymera Therapeutics's total revenue by fiscal year, normalized to USD alongside the as-reported original currency value.

Metric2025202420232022-2019
Total Revenue(USD)
39,211,000a
47,072,000a
78,592,000a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Kymera Therapeutics’s Revenues Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Kymera Therapeutics's 10-K 2025